Description
Relieves Osteoarthritic Pain
S-Adenosyl-L-Methionine (SAMe) has several critical physiological functions and is the common thread between three key metabolic pathways. Well-recognized as a unique methyl donor for more than 100 biological reactions, including DNA methylation. It also links methylation to polyamine synthesis (necessary for cell survival and growth) and transsulfuration, which is responsible for cysteine production, the rate-limiting factor in glutathione synthesis.2,3 Its unique positioning within these intersecting pathways explain its role as a regulator of redox status, cellular metabolism, proliferation, and apoptosis.4,5
Clinically proven to support a number of conditions, most notably osteoarthritis, fibromyalgia, neurodegenerative disease, depression, and liver disease.6,7 For patients with major depressive disorder, SAMe has been shown to be effective not only when compared to standard antidepressants, but also for selective serotonin reuptake inhibitor (SSRI) non-responders.8,9 SAMe has also shown efficacy for osteoarthritis comparable to NSAIDs, including celecoxib.11,12 Quite importantly, it is likely via increases in cartilage formation, glutathione production, DNA methylation, and gene expression which contribute to its efficacy, a stark contrast from pharmaceutical analgesics.13 Research also suggests benefit for neurodegenerative disease, and potentially for improving endothelial function.14-17
Benefits
- Key factor in several key biological pathways, including methylation reactions, glutathione formation and glutathione-s-transferase activity
- Complexed with disulfate tosylate, a well-tolerated, stable and clinically tested form
- Enteric coating protects SAMe degradation from gastric acid, allowing for significantly improved intestinal absorption
- 200 mg SAMe per tablet, allows for flexible dose titration
- Sourced from the highest quality Italian Isoactive SAMe available on the market
- Isoactive SAMe uses a natural fermentation process that yields 40% higher active ingredients over synthetic variations
- 30 Delayed-Release Tablets
- NPN: 80113412
Ingredients
Serving Size: 1 Tablet
Servings Per Container: 30
Each Tablet Contains:
SAMe S-Adenosyl Methionine
(from 400 mg SAMe Tosylate Disulfate)....................................200 mg
Non-medicinal Ingredients
Microcrystalline cellulose, mannitol, enteric coating (methacrylic acid copolymer, triethyl citrate, glyceryl palmito-stearate, silica, titanium dioxide, medium chain triglycerides, yellow iron oxide), glyceryl behenate, vegetable grade magnesium stearate (lubricant), silica, sodium starch glycolate.
Allergens
Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, soy, corn, egg, fish, shellfish, salt, tree nuts, or GMOs.
Dosage
Recommended Adult Dose: SAMe should always be taken on an empty stomach and for a minimum of 2 weeks, at which time effects should be observed.
For mood balance: 1-4 tablets 2 times per day or as directed by a health care practitioner. Consult a health care practitioner for use beyond 6 weeks.
For osteoarthritic pain: 2 tablets 3 times per day or as directed by a health care practitioner. Not to exceed 6 tablets per day. Consult a health care practitioner for use bevond 12 weeks.
Contraindications
Consult a health care practitioner if you are taking antidepressant medications. Do not use if you are pregnant or breastfeeding. Do not take at night as SAMe may cause anxiety, restlessness and insomnia. People with bipolar disorder (manic depressive illness) should not use SAMe unless under medical supervision. Possible side effects are: mild gastrointestinal upsets, anxiety, hyperactive muscle movement, insomnia and hypomania. When these side effects occur, they often diminish with time or resolve with lower doses or cessation of use. SAMe could theoretically worsen Parkinson’s symptoms, although this has not been observed clinically. Keep out of reach of children.
Drug Interactions
Deficiency of vitamins B6, B12, and other methyl donors may exacerbate SAMe deficiency. Theoretically may have additive serotonergic effects when used with antidepressants, but this has not been observed clinically, and when used simultaneously, no increase in adverse effects were noted compared to placebo.
